How to Run a Medicare DMEPOS Price Comparison Without Compliance Pitfalls

Comparing prices for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) is becoming a more routine part of operational review for suppliers, billers, and healthcare administrators. Yet the process carries specific compliance risks under Medicare rules. A price comparison that is not structured carefully can trigger overpayment demands, audit scrutiny, or even fraud referrals. The challenge is balancing market awareness with the regulatory boundaries that define Medicare reimbursement.

Recent Trends

Medicare has sharpened its focus on DMEPOS pricing over the past several years through increased prior authorization requirements, expanded competitive bidding programs, and more aggressive use of data analytics to flag outlier billing patterns. Suppliers are responding by benchmarking their own charges against regional and national fee schedules, but many are doing so without a clear compliance framework.

Key developments shaping the current landscape include:

• Greater reliance on the Medicare Administrative Contractor (MAC) pricing data and local coverage determinations.
• Renewed attention to the "reasonable charge" concept for non-competitive bidding areas.
• Growing use of real-time claims data by third-party vendors that offer price comparison tools.
• Increased scrutiny of suppliers who bill amounts significantly above the prevailing fee schedule.

Background

DMEPOS suppliers are generally reimbursed based on the lesser of the actual charge or the Medicare fee schedule amount. In competitive bidding areas, reimbursement is tied to the single payment amount established through the bidding process. Outside those areas, the fee schedule still governs, but suppliers retain discretion in setting their submitted charges.

The compliance risk does not come from running a price comparison itself. It comes from how the comparison is applied. Suppliers may inadvertently base their charges on competitor pricing that was set under different geographic or product-classification rules, or they may use comparison data to justify charge amounts that create audit red flags. Medicare expects charges to be consistent, accurate, and reflective of the supplier's own cost and market position—not simply matched to the highest observed amount.

User Concerns

Suppliers and compliance officers commonly raise several practical concerns when conducting a DMEPOS price comparison:

• Fee schedule accuracy: Using outdated or regionally incorrect fee schedules can lead to improper charge setting.
• Product classification errors: Comparing prices for items that differ in HCPCS coding, modifiers, or product features can distort results.
• Competitive bidding boundaries: A price that is valid in a non-competitive bidding area may be irrelevant or non-compliant in a competitive bidding area.
• Documentation burden: Even a defensible price comparison must be documented if it is used to support billing decisions during an audit.
• Anti-kickback and inducement risks: Sharing price comparison data with referral sources or using it to structure discounts may implicate federal fraud and abuse statutes.

These concerns are not theoretical. Auditors frequently ask suppliers to explain how their submitted charges were determined, and vague or undocumented answers can escalate a routine review into a broader investigation.

Likely Impact

When handled correctly, a DMEPOS price comparison can support operational efficiency, help suppliers identify improper billing patterns, and provide a defensible rationale for charge amounts. When handled poorly, the impact can include:

• Claims denials and demands for recoupment of overpayments.
• Placement on prepayment review or targeted probe review by the MAC.
• Referral to the Office of Inspector General for potential false claims liability.
• Loss of supplier billing privileges in severe cases.

The broader industry impact is a growing divide between suppliers who treat price comparison as a disciplined compliance function and those who treat it as a simple revenue optimization exercise. The former group tends to build internal controls around pricing; the latter often finds itself reacting to audit findings.

What to Watch Next

Suppliers should monitor several areas as the regulatory environment continues to evolve:

• Changes to the DMEPOS fee schedule: Annual updates and periodic adjustments can shift the competitive landscape.
• Expansion of prior authorization: Higher-risk items are increasingly subject to mandatory review before a claim is submitted, making pricing accuracy more consequential.
• Use of artificial intelligence in claims review: MACs and contractors are deploying machine learning tools that can detect unusual charge patterns more quickly and with less human oversight.
• Rebalancing of competitive bidding areas: If the Centers for Medicare & Medicaid Services expands or modifies bidding regions, suppliers in affected areas will need to revisit their comparison methodology.

In the near term, the safest approach is to treat every price comparison as a structured, documented exercise. That means defining the exact product and code set, using the correct regional fee schedule, recording the date and source of the comparison data, and retaining the analysis in case a MAC or auditor requests it. A price comparison that is reproducible and well-documented is far more likely to withstand scrutiny than one assembled informally.